z-logo
open-access-imgOpen Access
Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5‑FU chemotherapy by blocking the carcinogenic effect of YY1
Author(s) -
Liang Shan,
T. Xiang,
Shiyu Liu,
Xiang Wang
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11538
Subject(s) - oncogene , cancer , blocking (statistics) , cancer research , oncology , chemotherapy , molecular medicine , apoptosis , cell cycle , carcinogen , medicine , biology , computer science , genetics , computer network

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here